Perfinity iDP System - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Perfinity iDP System


Shimadzu’s the Perfinity iDP* (integrated Digestion Platform) online enzyme digestion HPLC system fully automates all processes from the enzymatic digestion of protein samples to the HPLC analysis of digested peptides. The Perfinity iDP uses a high-efficiency immobilized trypsin column for the online enzymatic digestion of proteins, it permits the online enzymatic digestion of proteins in less than one minute. The system iDP improves the analysis throughput by performing parallel processing of the stages from trypsin digestion to concentration in the desalting column and the stages from elution out of the desalting column to HPLC analysis. The easy-to-use software supports method creation and selection for the series of processes from trypsin digestion to desalting and HPLC analysis. An LC/MS can be added as a detector to automate the entire process up to analysis. Compared to conventional manual operations, the iDP offers more uniform control across the board and improves accuracy.

* Perfinity iDP is a registered trademark of Perfinity Biosciences, Inc.

Shimadzu Europa GmbH, Duisburg, Germany.
www.shimadzu.eu
shimadzu@shimadzu.eu

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here